| Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism BM Bayer, S Daussin, M Hernandez, L Irvin Neuropharmacology 29 (4), 369-374, 1990 | 244 | 1990 |
| Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord M Nakamura, RA Houghtling, L MacArthur, BM Bayer, BS Bregman Experimental neurology 184 (1), 313-325, 2003 | 230 | 2003 |
| Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism (s) of action RD Mellon, BM Bayer Journal of neuroimmunology 83 (1-2), 19-28, 1998 | 211 | 1998 |
| Immunosuppression by morphine is mediated by central pathways. MC Hernandez, LR Flores, BM Bayer The Journal of pharmacology and experimental therapeutics 267 (3), 1336-1341, 1993 | 170 | 1993 |
| In vivo effects of cocaine on immune cell function T Pellegrino, BM Bayer Journal of neuroimmunology 83 (1-2), 139-147, 1998 | 106 | 1998 |
| Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking. LR Flores, SM Wahl, BM Bayer The Journal of pharmacology and experimental therapeutics 272 (3), 1246-1251, 1995 | 105 | 1995 |
| Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin. BM Bayer, HS Kruth, M Vaughan, MA Beaven The Journal of Pharmacology and Experimental Therapeutics 210 (1), 106-111, 1979 | 95 | 1979 |
| Role of central 5-HT2 receptors in fluoxetine-induced decreases in T lymphocyte activity TC Pellegrino, BM Bayer Brain, Behavior, and Immunity 16 (2), 87-103, 2002 | 94 | 2002 |
| Opioids, immunology, and host defenses of intravenous drug abusers NC Alonzo, BM Bayer Infectious Disease Clinics 16 (3), 553-569, 2002 | 87 | 2002 |
| Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle BM Bayer, MA Beaven Biochemical pharmacology 28 (3), 441-443, 1979 | 86 | 1979 |
| Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration LR Flores, KL Dretchen, BM Bayer European journal of pharmacology 318 (2-3), 437-446, 1996 | 77 | 1996 |
| The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses RD Mellon, BM Bayer Journal of Pharmacology and Experimental Therapeutics 288 (2), 635-642, 1999 | 76 | 1999 |
| Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity RD Mellon, BM Bayer Brain research 789 (1), 56-67, 1998 | 76 | 1998 |
| Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility BM Bayer, MR Gastonguay, MC Hernandez Immunopharmacology 23 (2), 117-124, 1992 | 76 | 1992 |
| Morphine-induced conditioned taste aversions in the LEW/N and F344/N rat strains D Lancellotti, BM Bayer, JR Glowa, RA Houghtling, AL Riley Pharmacology Biochemistry and Behavior 68 (3), 603-610, 2001 | 75 | 2001 |
| Restraint stress-induced elevations in plasma corticosterone and β-endorphin are not accompanied by alterations in immune function CM Flores, MC Hernandez, KM Hargreaves, BM Bayer Journal of neuroimmunology 28 (3), 219-225, 1990 | 73 | 1990 |
| Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland RA Houghtling, BM Bayer Journal of Pharmacology and Experimental Therapeutics 300 (1), 213-219, 2002 | 68 | 2002 |
| Evidence that prostaglandins do not have a role in the cytostatic action of antiinflammatory drugs MCF de Mello, BM Bayer, MA Beaven Biochemical pharmacology 29 (3), 311-318, 1980 | 68 | 1980 |
| Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan-induced inflammation in rats. AP Almeida, BM Bayer, Z Horakova, MA Beaven Journal of Pharmacology and Experimental Therapeutics 214 (1), 74-79, 1980 | 67 | 1980 |
| Modulation of immune cell function following fluoxetine administration in rats TC Pellegrino, BM Bayer Pharmacology Biochemistry and Behavior 59 (1), 151-157, 1998 | 66 | 1998 |
